Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
Advice for Newly Diagnosed Small Cell Lung Cancer Patients
PARP Inhibitors in Small Cell Lung Cancer
What's the Status and Potential Utility of Cabozantinib in Lung Cancer?
MK-3475 and its Efficacy in Lung Cancer
How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?
Do you see PARP inhibitors as a single drug therapy or more in a combination setting?
ALK Positive Lung Cancer Forum 2014: Repeat Biopsies
ALK Positive Lung Cancer Forum 2014: Next Generation ALK Inhibitors
ALK Positive Lung Cancer Forum 2014: Disease Progression While on Xalkori
ALK Positive Lung Cancer Forum 2014: Scanning for Progression
ALK Positive Lung Cancer Forum 2014: Risk of Flare After Stopping Targeted Therapy
ALK Positive Lung Cancer Forum 2014: Can I Pass ALK Onto My Children
ALK Positive Lung Cancer Forum 2014: Testing for ALK
ALK Positive Lung Cancer Forum 2014: Xalkori
ALK Positive Lung Cancer Forum 2014: ALK Rearrangements in Lung Cancer
Squamous Lung Cancer Part 5, Q and A Session (video)
Squamous Lung Cancer, Part 4: Immunotherapy (video)
Squamous Lung Cancer, Part 3: Treatment (video)
Squamous Lung Cancer, Part 2: Genomic Testing (video)
Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (video)
Create your
podcast in
minutes
It is Free
Good Mood Revolution
GRACEcast Pancreatic Cancer Audio
GRACEcast Radiation Oncology Audio
GRACEcast Head and Neck Cancer Video NEW
GRACEcast Kidney Cancer Video
GRACEcast Social Work and Coping Video